Keystone Heart starts new trial of TriGUARD 3 cerebral embolic protection device

Image: The trial will evaluate the the safety and efficacy of the next-generation Keystone Heart –TriGUARD 3 cerebral embolic protection device. Photo: courtesy of Keystone Heart.